NANCY TOWNSEND O'DAY: Open Payments
NPI 1063652261 · MILLSBORO, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,714 in 79 payments from 16 companies in 2025. Trend: 2023 $2,344 · 2024 $1,490 · 2025 $1,714
Food & beverage: $1,613Education: $101
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 13 | $371 |
| Janssen Biotech, Inc. | 15 | $207 |
| ABBVIE INC. | 13 | $197 |
| Regeneron Healthcare Solutions, Inc. | 5 | $162 |
| PFIZER INC. | 5 | $119 |
| Novartis Pharmaceuticals Corporation | 5 | $114 |
| GENZYME CORPORATION | 1 | $114 |
| UCB, Inc. | 4 | $98 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $84 |
| Galderma Laboratories, L.P. | 3 | $56 |
Products named: DUPIXENT, TALTZ, TREMFYA, Bimzelx, SKYRIZI, CIBINQO, ILUMYA, Rhapsido.
Industry payments across DE — which companies pay providers there.
